Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-06-08 @ 7:32 PM
Study NCT ID:
NCT05668767
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-12-30
First Post:
2022-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC
Sponsor:
Organization: